Swiss Eurostars-funded projects in progress

Eurostars is a joint program between EUREKA and the European Commission, co-funded from the national budgets of 36 Eurostars Participating States and Partner Countries and by the European Union through Horizon 2020. The program supports international innovative projects led by R&D-performing SMEs. With its bottom-up approach, Eurostars supports the development of rapidly marketable innovative products, processes and services that help improve the daily lives of people around the world.

Recently, a consortium of leading cancer centres and innovative healthcare companies,  received €1 million. The consortium is led by Novigenix, a life science startup based in Epalinges and aims to develop a blood-based test based on transcriptomic and epigenetic biomarkers for early detection and relapse monitoring in colorectal cancer patients. Moreover, the consortium will develop an automated and structured data analysis process, including the most advanced machine learning methods, and validate multi-omics signatures.

Thirteen projects involving supported in 2019
Every year, a significant number of Swiss startups benefit from the Eurostars program. In 2019,  20 Swiss-led projects, of which 13 involve Swiss startups received the Eurostars funds. The startup's projects are already in progress. They include;

RetinaAI medical – project: IMAGE-R: Image analysis system for automated diagnosis and management of retinal diseases

Hylomorph – CONFIRM: Conformal Biocompatible Coatings For Medical Implants and Devices

GTX Medical – CONFIRM!: CONFIRMative neuromodulation surgery for rehabilitating people with spinal cord injury

Hemotune – SEPurate: A novel blood purification device for treatment of sepsis, based on magnetic nanoparticles

ProtoShape – DIAManT: Direct Sensor Integration by Additive Manufacturing Technology

Bnovate Technologies – MultiSense Aqua: Automated Online Flow Cytometry for Real-time Monitoring of Bacteria and Particles in Drinking Water

Gynomsis – MEGAPIPELINE: MPEG-G Enabled Genome Analysis Pipeline

Lunaphore – NGISS: Next Generation In Situ Sequencing (NGISS)

Alveolix – AIM4DoC: Advanced Inhalation Model for Drug Discovery on Chip

Saverna Therpautics and Spirochem – BUTTERFLY: First small molecule drug inhibitor of microRNAs: Treatment for systemic lupus erythematosus

Insphero – PAN-KIT: Development of an optimised pancreatic cell tool kit to enable accelerated diabetes drug discovery

Insphero – project:  Immune-NOVA: Development of CMTM6 inhibitors: Modulation of PDL1 for cancer treatment

Qnami – TSAR: Temperature sensor with atomic resolution.